AI assistant
Sending…
Zura Bio Ltd — Director's Dealing 2023
May 22, 2023
33996_dirs_2023-05-22_05e8795f-76b8-4fc9-8621-e247e9479147.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zura Bio Ltd (ZURA)
CIK: 0001855644
Period of Report: 2023-05-18
Reporting Person: Howell Michael (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-18 | Class A Ordinary Shares | A | 114395 | $0.00 | Acquired | 114395 | Direct |
Footnotes
F1: The Reporting Person was granted an award of 114,395 Restricted Share Units ("RSUs") on May 18, 2023 (the "Grant Date"). Under the terms of the RSU grant, 25% of the RSUs vest on each of the anniversaries of the Grant Date, such that the RSUs vest equally over four years, subject to the Reporting Person's continued service with the Issuer.
More from Zura Bio Ltd
Proxy Solicitation & Information Statement
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 23
Director's Dealing
2026
Mar 2
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 23